First – if you're headed out to Boston for the HLTH conference starting October 17, keep an eye out for some of the Insider team! We'll be there moderating panels, catching up with sources, and keeping an eye out for more stories. Be sure to say hi!
And as always, if you're new to this newsletter, sign up here. Let's get to it.
There was a lot of news about COVID-19 booster shots this week.
But perhaps the most exciting news came on Thursday afternoon: an FDA advisory panel unanimously recommended that people in certain high-risk groups who got the Moderna COVID-19 vaccine should get a booster shot. As Andrew Dunn reports, the FDA often agrees with its advisory panel when making its official recommendations - though not always.
In other booster shot news, a recent study found that people who got the Johnson & Johnson COVID-19 vaccine actually had a better immune response when they got a Pfizer or Moderna booster.
An FDA advisory panel plans to make recommendations for a Johnson & Johnson booster shot on Friday afternoon.
UnitedHealth has made a fortune by keeping people out of the hospital. Now, the healthcare giant is turning its gaze back to hospital systems.
Shelby Livingston reports on UnitedHealth's new strategy: to partner with hospitals and provide them with administrative solutions like patient billing.
Just last week, UnitedHealth's Optum division inked a 10-year deal with health system SSM Health, one of the largest healthcare systems in the Midwest.
